These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 37873295)

  • 1. Immunotherapy for ovarian cancer is improved by tumor targeted delivery of a neoantigen surrogate.
    Scanlon LR; Gabor L; Khouri OR; Ahmad S; Levy E; Kuo DY; Lin K; Nevadunsky N; Gravekamp C
    bioRxiv; 2023 Nov; ():. PubMed ID: 37873295
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Selvanesan BC; Chandra D; Quispe-Tintaya W; Jahangir A; Patel A; Meena K; Alves Da Silva RA; Friedman M; Gabor L; Khouri O; Libutti SK; Yuan Z; Li J; Siddiqui S; Beck A; Tesfa L; Koba W; Chuy J; McAuliffe JC; Jafari R; Entenberg D; Wang Y; Condeelis J; DesMarais V; Balachandran V; Zhang X; Lin K; Gravekamp C
    Sci Transl Med; 2022 Mar; 14(637):eabc1600. PubMed ID: 35320003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicotinamide combined with gemcitabine is an immunomodulatory therapy that restrains pancreatic cancer in mice.
    Selvanesan BC; Meena K; Beck A; Meheus L; Lara O; Rooman I; Gravekamp C
    J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33154149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic treatments for metastatic cutaneous melanoma.
    Pasquali S; Hadjinicolaou AV; Chiarion Sileni V; Rossi CR; Mocellin S
    Cochrane Database Syst Rev; 2018 Feb; 2(2):CD011123. PubMed ID: 29405038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adding combination immunotherapy consisting of cancer vaccine, anti-PD-1 and anti-CSF1R antibodies to gemcitabine improves anti-tumor efficacy in murine model of pancreatic ductal adenocarcinoma.
    Saung MT; Zheng L
    Ann Pancreat Cancer; 2019 Dec; 2():. PubMed ID: 32405624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient identification of neoantigen-specific T-cell responses in advanced human ovarian cancer.
    Liu S; Matsuzaki J; Wei L; Tsuji T; Battaglia S; Hu Q; Cortes E; Wong L; Yan L; Long M; Miliotto A; Bateman NW; Lele SB; Chodon T; Koya RC; Yao S; Zhu Q; Conrads TP; Wang J; Maxwell GL; Lugade AA; Odunsi K
    J Immunother Cancer; 2019 Jun; 7(1):156. PubMed ID: 31221207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor effect of neoantigen-reactive T cells combined with PD1 inhibitor therapy in mouse lung cancer.
    Qin H; Hu H; Liao X; Zhao P; He W; Su X; Sun J; Li Q
    J Cancer Res Clin Oncol; 2023 Aug; 149(10):7363-7378. PubMed ID: 36933035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a new fusion-enhanced oncolytic immunotherapy platform based on herpes simplex virus type 1.
    Thomas S; Kuncheria L; Roulstone V; Kyula JN; Mansfield D; Bommareddy PK; Smith H; Kaufman HL; Harrington KJ; Coffin RS
    J Immunother Cancer; 2019 Aug; 7(1):214. PubMed ID: 31399043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-associated antigen expressing Listeria monocytogenes induces effective primary and memory T-cell responses against hepatic colorectal cancer metastases.
    Olino K; Wada S; Edil BH; Pan X; Meckel K; Weber W; Slansky J; Tamada K; Lauer P; Brockstedt D; Pardoll D; Schulick R; Yoshimura K
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3(Suppl 3):S597-607. PubMed ID: 21979110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silver nanoparticles enhance the apoptotic potential of gemcitabine in human ovarian cancer cells: combination therapy for effective cancer treatment.
    Yuan YG; Peng QL; Gurunathan S
    Int J Nanomedicine; 2017; 12():6487-6502. PubMed ID: 28919750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-tumor efficacy of folate modified PLGA-based nanoparticles for the co-delivery of drugs in ovarian cancer.
    Li S; Li X; Ding J; Han L; Guo X
    Drug Des Devel Ther; 2019; 13():1271-1280. PubMed ID: 31114163
    [No Abstract]   [Full Text] [Related]  

  • 12. Low Mutation Burden in Ovarian Cancer May Limit the Utility of Neoantigen-Targeted Vaccines.
    Martin SD; Brown SD; Wick DA; Nielsen JS; Kroeger DR; Twumasi-Boateng K; Holt RA; Nelson BH
    PLoS One; 2016; 11(5):e0155189. PubMed ID: 27192170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Agonist anti-GITR antibody significantly enhances the therapeutic efficacy of Listeria monocytogenes-based immunotherapy.
    Shrimali R; Ahmad S; Berrong Z; Okoev G; Matevosyan A; Razavi GSE; Petit R; Gupta S; Mkrtichyan M; Khleif SN
    J Immunother Cancer; 2017 Aug; 5(1):64. PubMed ID: 28807056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of gemcitabine and anti-PD-1 antibody enhances the anticancer effect of M1 macrophages and the Th1 response in a murine model of pancreatic cancer liver metastasis.
    Ho TTB; Nasti A; Seki A; Komura T; Inui H; Kozaka T; Kitamura Y; Shiba K; Yamashita T; Yamashita T; Mizukoshi E; Kawaguchi K; Wada T; Honda M; Kaneko S; Sakai Y
    J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33188035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunotherapy with Listeria reduces metastatic breast cancer in young and old mice through different mechanisms.
    Jahangir A; Chandra D; Quispe-Tintaya W; Singh M; Selvanesan BC; Gravekamp C
    Oncoimmunology; 2017; 6(9):e1342025. PubMed ID: 28932647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radioimmunotherapy of human pancreatic cancer xenografts in NOD-scid mice with [
    Boyle AJ; Cao PJ; Cai Z; Chan C; Hedley DW; Reilly RM
    Nucl Med Biol; 2020; 84-85():46-54. PubMed ID: 32062317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myeloid-derived suppressor cells have a central role in attenuated Listeria monocytogenes-based immunotherapy against metastatic breast cancer in young and old mice.
    Chandra D; Jahangir A; Quispe-Tintaya W; Einstein MH; Gravekamp C
    Br J Cancer; 2013 Jun; 108(11):2281-90. PubMed ID: 23640395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment management for
    Haist M; Stege H; Rogall F; Tan Y; von Wasielewski I; Klespe KC; Meier F; Mohr P; Kähler KC; Weichenthal M; Hauschild A; Schadendorf D; Ugurel S; Lodde G; Zimmer L; Gutzmer R; Debus D; Schilling B; Kreuter A; Ulrich J; Meiss F; Herbst R; Forschner A; Leiter U; Pfoehler C; Kaatz M; Ziller F; Hassel JC; Tronnier M; Sachse M; Dippel E; Terheyden P; Berking C; Heppt MV; Kiecker F; Haferkamp S; Gebhardt C; Simon JC; Grabbe S; Loquai C
    J Immunother Cancer; 2023 Sep; 11(9):. PubMed ID: 37730278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose metronomic gemcitabine pretreatments overcome the resistance of breast cancer to immune checkpoint therapy.
    Zheng X; Kuai J; Shen G
    Immunotherapy; 2023 Apr; 15(6):429-442. PubMed ID: 36880262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Curcumin improves the therapeutic efficacy of Listeria(at)-Mage-b vaccine in correlation with improved T-cell responses in blood of a triple-negative breast cancer model 4T1.
    Singh M; Ramos I; Asafu-Adjei D; Quispe-Tintaya W; Chandra D; Jahangir A; Zang X; Aggarwal BB; Gravekamp C
    Cancer Med; 2013 Aug; 2(4):571-82. PubMed ID: 24156030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.